Date:September 01, 2025
Bio Usawa, a company focused on producing life-saving, affordable monoclonal therapies for Africa and beyond, has signed an agreement with the Desai Law Group (DLG) of Gaborone, Botswana, represented by Eleng Mugabe. The new partnership is an important step In Bio Usawa’s commitment to work collaboratively in its mission to make proven biotherapies available and affordable across the Continent.
Founded in 2016, DLG is a top-tier corporate and commercial law firm in Botswana. The firm represents leading corporations, banking and financial institutions, regulators and high net worth entrepreneurs.
Eleng Mugabe, a Partner at DLG, specializes in advising on mergers and acquisitions, corporate finance, regulatory compliance and project development in various sectors. She serves on the Board of the Botswana Digital and Innovation Hub and formerly sat on the University of Botswana Council.
Bio Usawa looks forward to a fruitful and collaborative partnership with both Eleng Mugabe and the DLG team.
The Bio Usawa Biotechnology (BUI) delegation, led by Dr. Menghis Bairu, CEO, had the honor of meeting with Botswana’s Vice President and Minister of Fin…
August 2025Bio Usawa, a company focused on producing life-saving, affordable monoclonal therapies for Africa and beyond, congratulates Mina Adel, MPH, PMP on his a…
August 2025During the COECSA Congress, Bio Usawa’s leadership team paid a courtesy visit to the Director General of the Ethiopian Food and Drug Authority (EFDA), M…
August 2025